“The Committee will provide relevant skills and perspectives, in order to improve communication of benefits, risks, clinical outcomes and increase integration of patient perspectives into the regulatory process for medical devices,” CMS said. “It will perform its duties by discussing and providing advice and recommendation in ways such as: Identifying new approaches, promoting innovation, recognizing unforeseen risks or barriers, and identifying unintended consequences that could result from FDA policy.”
The committee will consist of nine core members knowledgeable in clinical research, primary care patient experience and the healthcare needs of U.S. patient populations.
More articles on health IT:
12 things to know about the rise of mHealth
Untangling the lingo: 10 most misused health IT terms
The EHR market: 13 latest news updates
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.